CHE Stock Recent News

CHE's earnings and revenues beat estimates in the fourth quarter of 2024.

Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cinc.

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more attractive to value investors?

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 27, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference cal.

CHE stays on investors' radar due to its robust prospects in the VITAS business and the resilient Roto-Rooter arm.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 43rd Annual JPMorgan Healthcare Conference on Tuesday, January 14, 2024, at approximately 10:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA. The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available approximately three hours after the live presentation and wi.

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two stocks is more attractive to value investors?